Login | Register

Low estrogen ‘improves efficacy’ of PARP inhibitors on womb cancer

Researchers have discovered that low hormone levels may make endometrial cancer tumors more sensitive to a class of medication called PARP inhibitors - drugs that induce cancer cell death. This is according to a study published in the journal Molecular Cancer Therapeutics.Endometrial cancer, also known as womb cancer, forms in the tissue lining of the uterus.

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *